Buprenorphine 50268-0129-15
- Manufacturer
- Avpak
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- March 19, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA201760
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
50268-0129-15Selected50 BLISTER PACK in 1 BOX (50268-129-15) / 1 TABLET in 1 BLISTER PACK (50268-129-11)